Ketoconazole: Clinical Trials

93 trials of Ketoconazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

83 completed, 7 terminated, 1 active not recruiting, 1 recruiting. 93 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 193Completed 83, Terminated 7, Active not recruiting 1, Recruiting 1, Withdrawn 1
Phase 24Terminated 3, Completed 1

Follow Ketoconazole: new trials by email Literature Review of Ketoconazole trials Research Report on Ketoconazole

Trials (filtered) newest first · largest first

All 93 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketoconazole Effects on the Daily Cortisol Rhythm in Mild Autonomous Cortisol Secretion
Ketoconazole - Mild Autonomous Cortisol Secretion
Phase 1RecruitingNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)362026-07-272026-08-31
Bioavailability of Levoketoconazole and Ketoconazole Tablets
Levoketoconazole, Ketoconazole - Healthy
Phase 1CompletedCortendo AB342019-12-162020-01-31
Hormonal Mechanisms of Sleep Restriction - Axis Study
Ketoconazole Pill, Ganirelix, Dexamethasone - Sleep Restriction
Phase 1Active not recruitingPeter y. Liu802017-05-082025-09-11
Fenretinide Lym-X-Sorb + Ketoconazole + Vincristine for Recurrent or Resistant Neuroblastoma
Fenretinide/LXS Oral Powder, Ketoconazole, Vincristine - Recurrent Neuroblastoma, Neuroblastoma
Phase 1TerminatedSouth Plains Oncology Consortium42014-05-012022-03-31
A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199
ABT-199, Ketoconazole - Non-Hodgkin's Lymphoma
Phase 1CompletedAbbVie122013-12-012017-11-20
A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma
ketoconazole, vemurafenib - Malignant Melanoma, Neoplasms
Phase 1WithdrawnHoffmann-La Roche2013-10-012016-11-02
Effect of Ketoconazole on the Pharmacokinetics of Refametinib
BAY86-9766, Ketoconazole - Drug Interactions
Phase 1CompletedBayer182013-09-012014-01-08
A Study of Baricitinib When Administered With Ketoconazole or Fluconazole in Healthy Participants
Baricitinib, Ketoconazole, Fluconazole - Healthy Volunteers
Phase 1CompletedEli Lilly and Company362013-08-012017-06-06
Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of NBI-98854 in Healthy Subjects
NBI-98854 50 mg capsule once daily, Ketoconazole 400 mg (200 mg twice daily) - Effect of Ketoconazole on the PK of NBI-98854 in Healthy Subjects
Phase 1CompletedNeurocrine Biosciences242013-07-012013-09-05
CC-223 and Ketoconazole Drug-Drug Interaction Study
CC-223, Ketoconazole - Healthy Volunteers
Phase 1CompletedCelgene142013-07-012019-11-12
The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream
LY2409021, Gemfibrozil, Ketoconazole - Healthy Volunteers
Phase 1CompletedEli Lilly and Company302013-05-012019-03-08
GSK239512 DDI Study
GSK239512, ketoconazole - Multiple Sclerosis
Phase 1CompletedGlaxoSmithKline222013-01-072017-07-26
Drug-drug Interaction Trial of BI 113608 in Combination With Ketoconazole and Voriconazole in Healthy Male Subjects
BI 113608, Ketoconazole, Voriconazole - Healthy
Phase 1CompletedBoehringer Ingelheim202013-01-012017-03-15
Study To Determine The Effect Of Food And Strong CYP3A4 Enzyme Inhibitor On PF-04449913 Drug Levels
PF-04449913, ketoconazole - Healthy Volunteers
Phase 1CompletedPfizer142012-12-012013-04-10
Phase I Study to Assess the Effect on Healthy Male Volunteers of Ketoconazole on the Pharmacokinetics of a Single Dose of AZD5069 Administered Orally.
AZD5069, Ketoconazole - Asthma,, Pharmacokinetics,
Phase 1CompletedAstraZeneca152012-12-012015-06-25
Identification and Evaluation of Endogenous Markers for the Assessment of CYP3A Activity
Midazolam, Ketoconazole, Rifampicin - Healthy
Phase 1CompletedSeoul National University Hospital162012-12-012014-05-26
Effect of Ketoconazole on Sufentanil NanoTab Pharmacokinetics
Sufentanil NanoTab (SUF NT) 15 mcg, Ketoconazole 400 mg, sufentanil NanoTab (SUF NT) 15 mcg - Pharmacokinetics
Phase 1CompletedTalphera, Inc192012-11-012016-11-04
Effect of Ketoconazole on the Pharmacokinetics of JNJ-38518168 in Healthy Volunteers
JNJ-38518168 3 mg, JNJ-38518168 30 mg, JNJ-38518168 10 mg - Healthy
Phase 1CompletedJanssen Research & Development, LLC332012-10-012013-07-16
Bioavailability of BI 144807 Given Alone and in Combination With Ketoconazole in Healthy Male Volunteers
Ketoconazole, BI 144807 - Healthy
Phase 1CompletedBoehringer Ingelheim242012-10-012013-05-16
A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors
Warfarin, Ketoconazole, Gemfibrozil - Cancer
Phase 1CompletedGlaxoSmithKline482012-09-032017-11-13

Showing 20 of 93. Sign in to see all of them.

Conditions studied

Neoplasms (7)  ·  Lymphoma (4)  ·  Alzheimer Disease (2)  ·  Asthma (2)  ·  Diabetes Mellitus, Type 2 (2)  ·  Hepatitis C (2)  ·  Lymphoma, Non-Hodgkin (2)  ·  Nausea (2)  ·  Neuroblastoma (2)  ·  Prostatic Neoplasms (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Recurrence (2)  ·  Vomiting (2)  ·  Autoimmune Diseases (1)  ·  Bacterial Infections (1)

Sponsors

GlaxoSmithKline (14)  ·  Boehringer Ingelheim (6)  ·  AstraZeneca (5)  ·  Pfizer (5)  ·  Abbott (4)  ·  Hoffmann-La Roche (4)  ·  Janssen Research & Development, LLC (4)  ·  Celgene (3)  ·  Eli Lilly and Company (3)  ·  Astellas Pharma Inc (2)  ·  Bristol-Myers Squibb (2)  ·  Genentech, Inc. (2)  ·  Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (2)  ·  National Cancer Institute (NCI) (2)  ·  Roswell Park Cancer Institute (2)

Countries

United States (58)  ·  United Kingdom (8)  ·  Germany (5)  ·  South Korea (5)  ·  Australia (4)  ·  Belgium (3)  ·  France (2)  ·  Netherlands (2)  ·  Spain (1)  ·  Sweden (1)

Top investigators

Anthony R Godfrey, Pharm.D. (1)  ·  Barry J Maurer, MD, PhD (1)  ·  Barry J. Maurer, MD, PhD (1)  ·  Bengt Larsson, Dr. (1)  ·  Bo Fransson, MD (1)  ·  Brendan Smyth (1)

Results publications

PMID 18451235, PMID 21480191, PMID 21642470, PMID 22174351, PMID 22393898, PMID 22510871, PMID 22534255, PMID 22845044, PMID 23750331, PMID 23754575, PMID 24417786, PMID 25047497, PMID 25100135, PMID 26381275, PMID 26872892, PMID 27317471, PMID 27859472, PMID 28783865, PMID 28800141, PMID 29500603, PMID 29856004

NIH funding

2009 (2), 2008 (1), P01CA081403 (1), P30CA013330 (1), P30CA014520 (1), P30CA016056 (1), U01CA062491 (1)